An experimental study on evaluation of chemical antagonists induced snake venom neutralization

Indian Journal of Medical Research

Volumn 107, Issue MAR., 1998, Pages 142-146

  Alam, M I ^a   Gomes, A ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

Chemical antagonists; Snake venom; Snake venom neutralization

Indexed keywords

2 HYDROXY 4 METHOXYBENZOIC ACID; ACETYLSALICYLIC ACID; ANISIC ACID; BENZOIC ACID DERIVATIVE; CHEMICAL COMPOUND; FIBRINOGEN; SALICYLIC ACID DERIVATIVE; SNAKE VENOM; SNAKE VENOM ANTISERUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; SNAKEBITE;

ANIMALS; BENZOATES; EVALUATION STUDIES; MALE; MICE; SALICYLIC ACIDS; SNAKE VENOMS;

EID: 0031894255     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Tsai L H, Yang L L, Chang C. Inactivation of Formosan snake venom in vivo by aristolochic acid, the chemical component of Aristolochia radix. Formosan Sci 1980; 34 : 40-5.
2. Nakagawa M, Nakanishi,K. Darko, LL Vick JA. Structure of cabenegrins A-I and A-II, potent antisnake venoms. Tetrahedron Lett 1982; 23 : 3855-8.
3. Akunyili DN, Akubue PI. Schumanniofoside, the antisnake venom principle from the stem bark of Schumanniophyton magnificum Harms. J Ethnopharmacol 1986; 18 : 167-72.
4. Crosland R D. Effect of drugs on the lethality in mice of the venoms and neurotoxins from sundry snakes. Toxicon 1991; 29: 613-31.
5. Knowles R. The mechanism and treatment of snake bite in India. Trans R Soc Trop Med Hyg 1921; 75 : 72-92.
6. Whitaker R. Common Indian snakes-A field guide. New Delhi : The Macmillan Co. of India Limited; 1983 : 94-5.
7. Reid HA, Theakston RDG. The management of snake bite. Bull World Health Organ 1983; 61 : 885-95.
8. Alam MI, Auddy B, Gomes A. Isolation, purification and partial characterization of Viper venom inhibiting factor from the root extract of the Indian medicinal plant Sarsaparilla (Hemidesmus indicus R.Br.). Toxicon 1994; 32 : 1551-7.
9. World Health Organization. Progress in the characterization of venoms and standardization of antivenoms, Offset Publication No. 58, Geneva : World Health Organization 1981; 22-4.
10. Theakston RDG, Reid HA. Development of simple standard assay procedures for the characterization of snake venoms. Bull World Health Organ 1983, 61 : 949-56.
11. Gomes A, Alam MI. Comparative evaluation of chemical antagonists against Indian viper and cobra venom (Abstract). Toxicon 1996; 34 : 161-2.
12. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983; 32 : 1141-8.
13. Rainsford KD. Aspirin and the salicylates. London: Butterworths 1984; 105-7.
14. Wagner H, Geyer B, Kiso Y, Hikino H, Rao G S. Coumestans as the main active principles of the liver drugs Eclipta alba and Wedelia calendulacea. Planta Med 1986; 5 370-4.
15. Wagner H, Wierer M, Bauer R. In vitro Hemmung der Prostaglandin - Biosynthese durch etherische ole und phenolische Verbindungen. Planta Med 1986; 3 : 184-7.
16. Alam M I, Studies on the antisnake venom activity of selected plants, Ph.D thesis, University of Calcutta, Calcutta. 1997.
17. Alam M I, Gomes A. Viper venom induced inflammation and free radicals formation inhibition by pure compound (2-hydroxy-4-methoxy benzoic acid) isolated and purified from Anantamul (Hemidesmus indicus R. Br.) root extract. Toxicon 1998 (in press).